Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects

被引:16
作者
Alkahtani, Saad [1 ]
AL-Johani, Norah S. S. [1 ]
Alarifi, Saud [1 ]
机构
[1] King Saud Univ, Coll Sci, Dept Zool, POB 2455, Riyadh 11451, Saudi Arabia
关键词
neurodegenerative diseases; central nervous system; Alzheimer's disease; Parkinson's disease; blood-brain barrier; oxidative stress; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; DRUG-DELIVERY; NEUROVASCULAR DYSFUNCTION; INNATE IMMUNITY; GENE-THERAPY; ASTROCYTES; HEALTH; BETA;
D O I
10.3390/ijms24021340
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases (NDs) are a major cause of disability and are related to brain development. The neurological signs of brain lesions can vary from mild clinical shortfalls to more delicate and severe neurological/behavioral symptoms and learning disabilities, which are progressive. In this paper, we have tried to summarize a collective view of various NDs and their possible therapeutic outcomes. These diseases often occur as a consequence of the misfolding of proteins post-translation, as well as the dysfunctional trafficking of proteins. In the treatment of neurological disorders, a challenging hurdle to cross regarding drug delivery is the blood-brain barrier (BBB). The BBB plays a unique role in maintaining the homeostasis of the central nervous system (CNS) by exchanging components between the circulations and shielding the brain from neurotoxic pathogens and detrimental compounds. Here, we outline the current knowledge about BBB deterioration in the evolving brain, its origin, and therapeutic interventions. Additionally, we summarize the physiological scenarios of the BBB and its role in various cerebrovascular diseases. Overall, this information provides a detailed account of BBB functioning and the development of relevant treatments for neurological disorders. This paper will definitely help readers working in the field of neurological scientific communities.
引用
收藏
页数:18
相关论文
共 138 条
[81]  
Mischel PS, 2003, BRAIN PATHOL, V13, P52
[82]   Alzheimer's disease: A matter of blood-brain barrier dysfunction? [J].
Montagne, Axel ;
Zhao, Zhen ;
Zlokovic, Berislav V. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (11) :3151-3169
[83]   Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine [J].
Nelson, Bryant C. ;
Johnson, Monique E. ;
Walker, Marlon L. ;
Riley, Kathryn R. ;
Sims, Christopher M. .
ANTIOXIDANTS, 2016, 5 (02)
[84]   Nanotechnology-based drug delivery for central nervous system disorders [J].
Nguyen, Thuy Trang ;
Nguyen, Thi Thuy Dung ;
Vo, Tuong Kha ;
Tran, Nguyen-Minh-An ;
Nguyen, Minh Kim ;
Van Vo, Toi ;
Van Vo, Giau .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 143
[85]   Role of Insulin Resistance in the Alzheimer's Disease Progression [J].
Nguyen, Thuy Trang ;
Ta, Qui Thanh Hoai ;
Nguyen, Thi Thuy Dung ;
Le, Thi Thuy ;
Vo, Van Giau .
NEUROCHEMICAL RESEARCH, 2020, 45 (07) :1481-1491
[86]   Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 [J].
Nichols, Emma ;
Steinmetz, Jaimie D. ;
Vollset, Stein Emil ;
Fukutaki, Kai ;
Chalek, Julian ;
Abd-Allah, Foad ;
Abdoli, Amir ;
Abualhasan, Ahmed ;
Abu-Gharbieh, Eman ;
Akram, Tayyaba Tayyaba ;
Al Hamad, Hanadi ;
Alahdab, Fares ;
Alanezi, Fahad Mashhour ;
Alipour, Vahid ;
Almustanyir, Sami ;
Amu, Hubert ;
Ansari, Iman ;
Arabloo, Jalal ;
Ashraf, Tahira ;
Astell-Burt, Thomas ;
Ayano, Getinet ;
Ayuso-Mateos, Jose L. ;
Baig, Atif Amin ;
Barnett, Anthony ;
Barrow, Amadou ;
Baune, Bernhard T. ;
Bejot, Yannick ;
Bezabhe, Woldesellassie M. Mequanint ;
Bezabih, Yihienew Mequanint ;
Bhagavathula, Akshaya Srikanth ;
Bhaskar, Sonu ;
Bhattacharyya, Krittika ;
Bijani, Ali ;
Biswas, Atanu ;
Bolla, Srinivasa Rao ;
Boloor, Archith ;
Brayne, Carol ;
Brenner, Hermann ;
Burkart, Katrin ;
Burns, Richard A. ;
Camera, Luis Alberto ;
Cao, Chao ;
Carvalho, Felix ;
Castro-de-Araujo, Luis F. S. ;
Catala-Lopez, Ferran ;
Cerin, Ester ;
Chavan, Prachi P. ;
Cherbuin, Nicolas ;
Chu, Dinh-Toi ;
Costa, Vera Marisa .
LANCET PUBLIC HEALTH, 2022, 7 (02) :E105-E125
[87]   EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS [J].
NUTT, JG ;
WOODWARD, WR ;
BECKNER, RM ;
STONE, CK ;
BERGGREN, K ;
CARTER, JH ;
GANCHER, ST ;
HAMMERSTAD, JP ;
GORDIN, A .
NEUROLOGY, 1994, 44 (05) :913-919
[88]   Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells [J].
Page, Shyanne ;
Patel, Ronak ;
Raut, Snehal ;
Al-Ahmad, Abraham .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (04)
[89]   Age-associated changes in microglia and astrocytes ameliorate blood-brain barrier dysfunction [J].
Pan, Jie ;
Ma, Nana ;
Zhong, Jie ;
Yu, Bo ;
Wan, Jun ;
Zhang, Wei .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 26 :970-986
[90]   Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow [J].
Pan, Qunwen ;
He, Caixia ;
Liu, Hua ;
Liao, Xiaorong ;
Dai, Bingyan ;
Chen, Yanfang ;
Yang, Yi ;
Zhao, Bin ;
Bihl, Ji ;
Ma, Xiaotang .
MOLECULAR BRAIN, 2016, 9